Sogroya
Active Ingredient(s): Sompacitan-becoFDA Approved: * August 28, 2020
Pharm Company: * NOVO NORDISK INC
Category: Growth Hormone Treatment
Somapacitan, sold under the brand name Sogroya, is a growth hormone medication.[5] Somapacitan is a human growth hormone analog.[2] Somapacitan-beco is produced in Escherichia coli by recombinant DNA technology.[2] The most common side effects include: back pain, joint paint, indigestion, a sleep disorder, dizziness, tonsillitis, swelling in the arms or lower legs, vomiting, adrenal insufficiency, hypertension, increase in blood creatine phospho... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.